Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Equity

v3.21.2
Consolidated Statements of Equity - USD ($)
Total
Series A, Internalization
Common Stock, Internalization
Class B Common Stock, Internalization
Class B Common Stock
Capital Stock
Capital Stock
Common Stock, Internalization
Common Stock
Common Stock
Class B Common Stock, Internalization
Common Stock
Class B Common Stock
Preferred Stock
Preferred Stock
Series A, Internalization
Additional Paid-in Capital
Additional Paid-in Capital
Series A, Internalization
Additional Paid-in Capital
Common Stock, Internalization
Additional Paid-in Capital
Class B Common Stock, Internalization
Retained Deficit
Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2019               13,638,916                    
Beginning balance at Dec. 31, 2019 $ 476,739,439             $ 13,639     $ 125,493,175   $ 360,844,497       $ (9,611,872)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) (162,042,368)                               (162,042,368)  
Series A preferred stock dividends (2,313,780)                       (2,313,780)          
Preferred stock repurchases [1] (161,997)                   (222,825)   7,932       52,896  
Common Stock dividends (10,238,640)                       (10,238,640)          
Common stock issued upon exchange of convertible notes (in shares)               12,605                    
Common Stock issued upon exchange of convertible notes 419,129             $ 13         419,116          
Ending balance (in shares) at Mar. 31, 2020               13,651,521                    
Ending balance at Mar. 31, 2020 302,401,783             $ 13,652     125,270,350   348,719,125       (171,601,344)  
Beginning balance (in shares) at Dec. 31, 2019               13,638,916                    
Beginning balance at Dec. 31, 2019 476,739,439             $ 13,639     125,493,175   360,844,497       (9,611,872)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) (303,395,899)                                  
Crimson A-2 Units dividends payment in kind 0                                  
Stock issued, value, internalization transaction   $ 0 $ 0 $ 0                            
Ending balance (in shares) at Sep. 30, 2020               13,651,521                    
Ending balance at Sep. 30, 2020               $ 13,652     125,270,350   342,734,629       (312,954,875)  
Beginning balance (in shares) at Mar. 31, 2020               13,651,521                    
Beginning balance at Mar. 31, 2020 302,401,783             $ 13,652     125,270,350   348,719,125       (171,601,344)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) (137,434,433)                               (137,434,433)  
Series A preferred stock dividends (2,309,672)                       (2,309,672)          
Common Stock dividends (682,576)                       (682,576)          
Ending balance (in shares) at Jun. 30, 2020               13,651,521                    
Ending balance at Jun. 30, 2020 161,975,102             $ 13,652     125,270,350   345,726,877       (309,035,777)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) (3,919,098)                               (3,919,098)  
Series A preferred stock dividends (2,309,672)                       (2,309,672)          
Common Stock dividends (682,576)                       (682,576)          
Ending balance (in shares) at Sep. 30, 2020               13,651,521                    
Ending balance at Sep. 30, 2020               $ 13,652     125,270,350   342,734,629       (312,954,875)  
Beginning balance (in shares) at Dec. 31, 2020         0 13,651,521       0                
Beginning balance at Dec. 31, 2020 149,399,827         $ 13,652       $ 0 125,270,350   339,742,380       (315,626,555) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) (10,694,263)                               (12,299,571) 1,605,308
Series A preferred stock dividends (2,309,672)                       (2,309,672)          
Common Stock dividends (682,576)                       (682,576)          
Equity attributable to non-controlling interest (Note 3) 115,323,036                                 115,323,036
Ending balance (in shares) at Mar. 31, 2021           13,651,521       0                
Ending balance at Mar. 31, 2021 251,036,352         $ 13,652       $ 0 125,270,350   336,750,132       (327,926,126) 116,928,344
Beginning balance (in shares) at Dec. 31, 2020         0 13,651,521       0                
Beginning balance at Dec. 31, 2020 149,399,827         $ 13,652       $ 0 125,270,350   339,742,380       (315,626,555) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) (2,346,883)                                  
Crimson A-2 Units dividends payment in kind $ (610,353)                                  
Stock issued, value, internalization transaction   4,245,112 7,096,153 3,288,890                            
Ending balance (in shares) at Sep. 30, 2021 14,866,799       683,761 14,866,799       683,761                
Ending balance at Sep. 30, 2021 $ 267,657,718         $ 14,866       $ 684 129,525,675   341,331,070       (324,749,301) 121,534,724
Beginning balance (in shares) at Mar. 31, 2021           13,651,521       0                
Beginning balance at Mar. 31, 2021 251,036,352         $ 13,652       $ 0 125,270,350   336,750,132       (327,926,126) 116,928,344
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) 2,427,409                               412,539 2,014,870
Series A preferred stock dividends (2,309,672)                       (2,309,672)          
Common Stock dividends (682,576)                       (682,576)          
Reinvestment of dividends paid to common stockholders (in shares)           21,805                        
Reinvestment of dividends paid to common stockholders 132,795         $ 21             132,774          
Crimson cash distribution on A-1 Units (604,951)                                 (604,951)
Crimson A-2 Units dividends payment in kind (406,000)                                 (406,000)
Equity attributable to non-controlling interest 1,288,726                                 1,288,726
Ending balance (in shares) at Jun. 30, 2021           13,673,326       0                
Ending balance at Jun. 30, 2021 250,882,083         $ 13,673       $ 0 125,270,350   333,890,658       (327,513,587) 119,220,989
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income (loss) 5,919,971                               2,764,286 3,155,685
Series A preferred stock dividends (2,388,130)                       (2,388,130)          
Common Stock dividends (741,530)                       (741,530)          
Reinvestment of dividends paid to common stockholders (in shares)           36,228                        
Reinvestment of dividends paid to common stockholders 174,619         $ 36             174,583          
Common stock issued under director's compensation plan           3,399                        
Common stock issued under director's compensation plan 22,500         $ 3             22,497          
Crimson cash distribution on A-1 Units (841,950)                                 (841,950)
Crimson A-2 Units dividends payment in kind (204,353)                                 (204,353)
Equity attributable to non-controlling interest $ 204,353                                 204,353
Stock issued, internalization transaction (in shares)             1,153,846   683,761                  
Stock issued, value, internalization transaction   $ 4,245,112 $ 7,096,153 $ 3,288,890     $ 1,154   $ 684     $ 4,255,325   $ (10,213) $ 7,094,999 $ 3,288,206    
Ending balance (in shares) at Sep. 30, 2021 14,866,799       683,761 14,866,799       683,761                
Ending balance at Sep. 30, 2021 $ 267,657,718         $ 14,866       $ 684 $ 129,525,675   $ 341,331,070       $ (324,749,301) $ 121,534,724
[1] In connection with the repurchase of Series A Preferred Stock during 2020, the deduction from preferred dividends of $52,896 represents the discount in the repurchase price paid compared to the carrying amount derecognized.